# CATIE-Alzheimer's Disease Trial

> **NCT00015548** · NA · COMPLETED · sponsor: **National Institute of Mental Health (NIMH)** · enrollment: 450 (—)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Olanzapine
- **DRUG:** Quetiapine
- **DRUG:** Risperidone
- **DRUG:** Citalopram

## Key facts

- **NCT ID:** NCT00015548
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** —
- **Final completion:** 2004-10
- **Target enrollment:** 450 (—)
- **Last updated:** 2015-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00015548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00015548, "CATIE-Alzheimer's Disease Trial". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00015548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*